Merck Announces VAR2 Pharmaceuticals as Winner of its Advance Biotech Grant
VAR2 Pharmaceuticals selected for its development of a drug-conjugated malaria protein
10-Jul-2020 -
Merck, a leading science and technology company, today announced that VAR2 Pharmaceuticals has been selected as the European winner of its 2020 Advance Biotech Grant Program. Copenhagen, Denmark-based biotechnology company VAR2 Pharmaceuticals was chosen for its development of a promising novel ...
cancer
cancer cells
Merck
+1